Get App
Download App Scanner
Scan to Download
Advertisement
LIVE UPDATES

Sensex, Nifty Trim Worst Monthly Loss Since 2016

Sensex, Nifty Trim Worst Monthly Loss Since 2016
A visitor uses a smartphone in front of an electronic ticker screen displaying current share prices. (Photographer: Yorgos Karahalis/Bloomberg)
8 years ago
Nifty future on Singapore Exchange rose 0.3% indicating positive start for Indian shares.

Shares of the Anil Ambani-led company rose as much as 3.8 percent to Rs 472.20 after it won arbitration award against the Goa government.

Reliance Infra will get Rs 292 crore from the Goa government by April 2018. The company's claim was against prolonged non-payment by the Goa government towards supply of electricity from its 48-megawatt Goa power plant.

India's largest mortgage lender Housing Development Finance Corporation Ltd. is set to sell shares to institutional investors to raise about Rs 1,900 crore as part of its Rs 13,000-crore plan to mop up funds to invest in its banking and other subsidiaries.

The housing finance company will launch a qualified institutional placement this week, two people privy to the proposed transaction told BloombergQuint on condition of anonymity. The demand and initial feedback from large marquee investors is quite strong, one of them said.

Shares of HDFC were trading 1 percent higher at Rs 1,844.

  • Shares of the Anil Ambani-led company rose as much as 8.5 percent to Rs 29.90 after 20 lakh shares changed hands in a block deal.
  • Buyers and sellers were not immediately known

    Source: Bloomberg

  • Indian equity benchmarks extended gains led by private sector lenders, car makers and energy shares.
  • The S&P BSE Sensex rose 0.9 percent or 313 points to 34,455 and the NSE Nifty 50 Index gained 0.87 percent or 92 points to 10,583.
  • Seventeen out of 19 sector gauges compiled by BSE were trading higher led by the S&P BSE Realty Index's 2 percent gain. On the other hand, the S&P BSE IT index was the top sectoral loser, down 0.7 percent.
  • Gains were broad-based as the S&P BSE MidCap Index rose 0.8 percent and the S&P BSE SmallCap Index advanced 0.9 percent.

  • Motherson Sumi has 23 lakh shares change hands in a block deal.
  • Buyers and sellers were not immediately known

    Source: Bloomberg

Shares of the adhesive maker were trading 0.7 percent higher at Rs 903 after the board of directors announced share buyback offer of 50 lakh equity shares at Rs 1,000 each amounting to Rs 500 crore.

Shares of the Mumbai-based agricultural commodities importer and exporter rose as much as 2.59 percent to Rs 205.30 after it submitted expression of interest to acquire debt ridden Ruchi Soya Industries.

Shares of the Bangalore-based drug maker rose as much as 2.8 percent to Rs 712.50 after the company launched Rantidine OTC tablets, it said in a press release.

Ranitidine tablet is the generic form of the popular brand Zantac and is used to treat peptic ulcers of stomach and intestines.

The drug has market of $200 million in U.S. according to IRI data and will be manufactured from its 50:50 joint venture facility with Vivimed Labs in Chennai.

Shares of the Chennai-based two-wheeler maker rose as much as 1.7 percent to Rs 678.20 ahead of its meeting of its board members with fund managers on March 2.

Shares of the Pune-based optical fibre communications equipment maker rose as much as 10.22 percent to Rs 378.75 after it secured Rs 3,500 crore advance purchase order to design, build and manage Indian Navy’s communications network.

Shares of Aster DM Healthcare got listed at Rs 182, at a discount of 4.2 percent, against its issue price of Rs 190.

The stock fell as much as 7.36 percent to Rs 176.45.

Aster DM Healthcare Ltd.’s Rs 980-crore initial public offering was subscribed 1.3 times on the third and final day of bidding so far.

Shares of the state-run lender fell as much as 12.5 percent to Rs 92.50 after the CBI registered a case of fraud against a loan provided by the bank to Simbhaoli Sugars.

Shares of Aster DM settled at Rs 182/share on BSE versus its issue price of Rs 190/share in pre-open trade.

Shares of the Hyderabad-based drug maker fell as much as 4.11 percent to Rs 2,080 after the U.S. drug regulator issued establishment inspection report (EIR) for its formulations facility in Srikakulam, Andhra Pradesh.

The company, without mentioning the contents of the EIR, said the USFDA has maintained OAI (Official Action Indicated) status at its API manufacturing plant in Srikakulam.

Shares of the Hapur-based sugar maker fell as much as 20 percent to Rs 13.50 after the Central Bureau of Investigation registered FIR against Simbhaoli Sugar and its top management for causing loss of Rs 109 crore to government-owned Oriental Bank of Commerce.

  • Bharti Infratel has 37.5 lakh shares change hands in a block deal.
  • Coffe Day Enterprises has 55 lakh shares change hands in a block deal.
  • Buyers and sellers were not immediately known

    Source: Bloomberg

In focus this week is the GDP data which is likely to show that Indian economy grew at 6.9 percent in October-December, at a pace faster than the previous quarter. Also, all eyes will be on new U.S. Fed chairman Jerome Powell who has two appearances this week. There is a growing view that the new Fed chief may stick to the path of gradual rate increases as was set out by his predecessor Janet Yellen. On the home front, higher inflation may lead RBI to hike rates which is keeping bond traders on the edge.

Benchmark yields fell 8 basis points on Friday, but traders don't expect further rally from here. Yield on the 10-year note may stay in a range of 7.64 percent-7.74 percent.

In the currency market, rupee's implied opening from forwards suggest a level of 64.85 a dollar. Local equities are trading strong that may help support the unit. A range of 64.60-65 a dollar is expected in the session.

HSBC on ICICI Lombard

  • Initiated ‘Reduce’ with price target of Rs 610; implying a potential downside of 25 percent form last regular trade.
  • Gross written premium to grow slower than industry rate due to competition.
  • High dependency on three segments – motor, crop and health insurance.
  • Life players could enter the health market.
  • Three regions account for 48 percent of its premiums.
  • Emergence of a stronger competitor is a possibility.
  • Profitability to improve due to fall in the loss ratio.
  • Expect net income to compound at 29 percent over the fiscal 2017-2020.
  • Passage of the motor vehicle bill is the key upside risk.
  • Stock trades at a high valuation.

CLSA on Supreme Industries

  • Initiated ‘Buy’ with price target of Rs 1,482; implying a potential upside of 25 percent from yesterday’s close.
  • Impressive growth track record with superlative capital returns.
  • Diversified product offering; Focusing on value-added products.
  • Efficient capital allocation; Generated superlative ROCEs in capital-intensive industry.
  • Expect free cash flow with balance sheet to turn net cash by March 2020.
  • Expect earnings per share to compound at 25 percent through the financial years till March 2020.
  • Deserves to trade at premium.

Nomura on Sun Pharma

  • Maintained ‘Neutral’ with price target of Rs 479.
  • Number of observations limited to three for a large plant inspected over two weeks.
  • Appears to be a good outcome.
  • Difficult to predict timelines for FDA action; Expect issuance of EIR to take six months.
  • Outcome of Halol FDA inspection is not a significant positive, given current expectations.
  • Key for Sun Pharma is trajectory of the specialty business.

Jefferies on Sun Pharma

  • Maintained ‘Hold’ with price target of Rs 520.
  • Halol gets 3 observations; Severity unknown.
  • Halol resolution is a key near-term trigger for Sun Pharma.
  • Halol is key driver to earnings recovery; Expect resolution in current quarter.
  • Earnings recovery to be gradual as investment in specialty to continue.

IDFC Securities United Spirits

  • Maintained ‘Neutral’ with price target of Rs 3,336.
  • Impact from route to market (RTM) to recede in the current quarter.
  • Franchise benefits to accrue through March 2018.
  • Lower molasses prices to benefit near term margins.
  • Remain positive on broader premiumisation and return and margin-accretive growth strategy.
  • Valuations leave little room for upside; Await better entry point.

IDFC Securities on Redington India

  • Maintained ‘Outperform’ with price target of Rs 224.
  • India IT enterprise business could pick up pace.
  • Change in leadership at Apple India would be positive.
  • India business to be driven by Enterprise/non-Apple Mobility.
  • India Working capital (WC) to improve; Overseas WC not sustainable.
  • Scaling up a priority for ProConnect; Open to listing ProConnect.

IDFC Securities on United Breweries

  • Maintained ‘Outperform’ with price target of Rs 1,333
  • Volume trajectory to remain healthy in the current quarter.
  • Early signs of rationalising competitive intensity.
  • Market share gains could continue.
  • Expect strong double-digit volume growth over next two quarters.
  • Healthy growth outlook; attractive valuations.

  • U.S. FDA maintains OAI (Official Action Indicated) status on Dr. Reddy’s Srikakulam plant.
  • Idea Cellular said it will continue to evaluate options to monetise Indus stake (Bloomberg).
  • Bharti Airtel, Motorola partner to offer 4G smartphone.
  • DCM Shriram to invest Rs 113 crore for expansion of Caustic soda capacity at its Bharuch facility.
  • Sakuma Exports have submitted an expression of interest to acquire Ruchi Soya.
  • Sadbhav Infra unit Bhilwara-Rajsamanad tollway completes debt refinancing.
  • Idea Cellular raises Rs 3,500 crore via QIP.
  • Dena Bank sets issue price at Rs 26.89 per share for issue of shares to the government.
  • PNB denies report that PWC is engaged in probing alleged fraud.
  • Welspun Enterprises said it is lowest bidder for NHAI Tamil Nadu road project.

  • Nifty March Futures closed trading at 10,504.5, premium of 13 points versus 6 points.
  • All series-Nifty OI up 5 percent, Bank Nifty OI up 5 percent.
  • India VIX ended at 14.2, down 4 percent.
  • Max OI for March series at 10,700 call strike , OI at 29 lakh, OI up 16 percent.
  • Max OI for March series at 10,000 Put, OI at 35.4 lakh, up 9 percent.

  • Hindcon Chemicals: Seeks to raise Rs 7.73 crore in an initial public offering that will close on Feb. 28
  • Aster DM Healthcare lists today with a base price of Rs 190 per share. Its IPO was subscribed 1.3 times.

  • Fortis Healthcare: BNP Paribas Arbitrage bought 42.75 lakh shares or 0.8 percent equity stake at Rs 154.91 each.
  • Apollo Pipes: Laburnum capital advisors bought 67,000 shares, or 0.6 percent equity at Rs 561.99 each.
  • Finolex Industries: Prescient Wealth Management Private Limited sold 7.98 lakh shares, or 0.6 percent equity at Rs 629 each.
  • Chembond Chemicals: Promoter Perviz Homi Dastur sold 1.30 lakh shares, or 1 percent equity at Rs 297.4 each.
  • Jaypee Infratech: IndusInd Bank Ltd. Client A/c sold 1.1 crore shares, or 0.8 percent equity at Rs 13.65 each.
  • Dollar Industries: Shakuntala Exim Pvt Ltd. sold 3 lakh shares, or 0.5 percent equity at Rs 420.3 each.
  • Jubilant Lifesciences

    • Copthall Mauritius Investment bought 27.50 lakh shares, or 1.7 percent equity at Rs 914 each.
    • Promoter Jubilant Advisors LLP sold 22.38 lakh shares, or 1.4 percent equity at Rs 917.43 each.
    • Promoter Jubilant Consumer Pvt Ltd sold 27.36 lakh shares, or 1.7 percent equity at Rs 914 each.

    Shiva Texyarn

    • Care Portfolio managers bought 78,000 shares, or 0.6 percent equity at Rs 540 each.
    • Promoter S V Kandasami sold 1.31 lakh shares, or 1 percent equity at Rs 543.11 each.

  • 02/25-02/28: Eight infrastructure industries index for Jan. (prior +4.0%)

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search